2012-10-09 00:22:36 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Norgine B.V - Product Pipeline Review - 2012" provides data on the Norgine B.V's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Norgine B.V's corporate website, SEC filings, investor presentations and featured press releases, both from Norgine B.V and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Norgine B.V - Brief Norgine B.V overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Norgine B.V human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Norgine B.V with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Norgine B.V's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468567_norgine_bv_product_pipeline_review_20 ..


Reasons to buy

* Evaluate Norgine B.V's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Norgine B.V in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Norgine B.V's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Norgine B.V.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Norgine B.V and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Norgine B.V Snapshot
Norgine B.V Overview
Key Information
Key Facts
Norgine B.V - Research and Development Overview
Key Therapeutic Areas
Norgine B.V - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Norgine B.V - Pipeline Products Glance
Norgine B.V - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Norgine B.V Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Norgine B.V - Drug Profiles
MoviPrep
Product Description
Mechanism of Action
R&D Progress
ulimorelin hydrochloride
Product Description
Mechanism of Action
R&D Progress
Norgine B.V - Pipeline Analysis
Norgine B.V - Pipeline Products by Therapeutic Class
Norgine B.V - Pipeline Products by Route of Administration
Norgine B.V - Recent Pipeline Updates
Norgine B.V - Dormant Projects
Norgine B.V - Locations And Subsidiaries
Head Office
Norgine B.V, Recent Developments
Norgine B.V- Press Release
Aug 07, 2012: Modi-Mundipharma Launches Movicol In India
Mar 29, 2012: Norgine Enforces Trademark Rights In Movi-Prefix, Forces Rebranding Of Two Laxatives
Feb 29, 2012: Ajinomoto Pharmaceuticals Files Application For Manufacture And Marketing Authorization Of New Oral Bowel Cleansing Agent In Japan
Apr 23, 2009: Norgine Partners With PharmaSwiss For MOVIPREP In Eastern Europe
Financial Deals Landscape
Norgine B.V, Deals Summary
Norgine B.V, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Norgine Acquires Cetilistat From Alizyme Therapeutics
Partnerships
Norgine Enters Into Co-Marketing Agreement With Modi Mundipharma
Norgine Enters Into Co-Marketing Agreement With Alfa Wassermann
Norgine Enters Into Co-Marketing Agreement With PharmaSwiss For Moviprep
Licensing Agreements
Tranzyme Pharma Enters Into Licensing Agreement With Norgine
Norgine Enters Into Licensing Agreement With Pegasus Biosolutions
Norgine Expands Licensing Agreement With Medical Futures For NORMACOL
APR Applied Pharma Research And Labtec Enters Into Licensing Agreement With Norgine For Setofilm
Salix Pharma And Norgine Enter Into Licensing Agreement With Novel Labs
Santarus Enters Into Licensing Agreement With Norgine
Asset Transactions
Meda Acquires Pyralvex, Spasmonal And Waxsol From Norgine
Acquisition
Norgine Acquires 12.61% Stake In ProStrakan
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Norgine B.V, Key Information
Norgine B.V, Key Facts
Norgine B.V - Pipeline by Indication, 2012
Norgine B.V - Pipeline by Stage of Development, 2012
Norgine B.V - Monotherapy Products in Pipeline, 2012
Norgine B.V - Filed, 2012
Norgine B.V - Phase III, 2012
Norgine B.V - Phase II, 2012
Norgine B.V - Pipeline By Therapeutic Class, 2012
Norgine B.V - Pipeline By Route of Administration, 2012
Norgine B.V - Recent Pipeline Updates, 2012
Norgine B.V - Dormant Developmental Projects,2012
Norgine B.V, Deals Summary

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468567&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.